You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Goals and Challenges of Stem Cell-Based Therapy for Corneal Blindness Due to Limbal Deficiency
Contributor:
Calonge, Margarita;
Nieto-Miguel, Teresa;
de la Mata, Ana;
Galindo, Sara;
Herreras, José M.;
López-Paniagua, Marina
Published:
MDPI AG, 2021
Published in:
Pharmaceutics, 13 (2021) 9, Seite 1483
Language:
English
DOI:
10.3390/pharmaceutics13091483
ISSN:
1999-4923
Origination:
Footnote:
Description:
Corneal failure is a highly prevalent cause of blindness. One special cause of corneal failure occurs due to malfunction or destruction of the limbal stem cell niche, upon which the superficial cornea depends for homeostatic maintenance and wound healing. Failure of the limbal niche is referred to as limbal stem cell deficiency. As the corneal epithelial stem cell niche is easily accessible, limbal stem cell-based therapy and regenerative medicine applied to the ocular surface are among the most highly advanced forms of this novel approach to disease therapy. However, the challenges are still great, including the development of cell-based products and understanding how they work in the patient’s eye. Advances are being made at the molecular, cellular, and tissue levels to alter disease processes and to reduce or eliminate blindness. Efforts must be coordinated from the most basic research to the most clinically oriented projects so that cell-based therapies can become an integrated part of the therapeutic armamentarium to fight corneal blindness. We undoubtedly are progressing along the right path because cell-based therapy for eye diseases is one of the most successful examples of global regenerative medicine.